Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease
{{output}}
Objective. The objective of the present study is to investigate the effect of rosiglitazone, metformin, ezetimibe, and valsartan (alone or in combinations) on paraoxonase (PON) activity and PON-mRNA expression in nonalcoholic fatty liver disease (NAFLD). Metho... ...
